Reducing The Cancer Burden
Between 30 and 50% of cancers can currently be prevented by avoiding risk factors and implementing existing evidence-based prevention strategies. The cancer burden can also be reduced through early detection of cancer and appropriate treatment and care of patients who develop cancer. Many cancers have a high chance of cure if diagnosed early and treated appropriately.
What Are The Statistics For Prostate Cancer
-
The rate of prostate cancer is higher in African-American men than white men. African-American men are also more than twice as likely to die from prostate cancer. The reasons why are not known. But some risk factors may play a part, such as differences in genes.
-
About 164,690 men in the U.S. will get prostate cancer in 2018. It is the most common cancer in men, not including skin cancer. Nearly 2 out of 3 of these men will be age 65 or older.
-
Prostate cancer is the second leading cause of cancer death in men in the U.S. after lung cancer. About 29,430 men will die of prostate cancer in 2018.
What Is A Normal Psa Test Result
There is no specific normal or abnormal level of PSA in the blood, and levels may vary over time in the same man. In the past, most doctors considered PSA levels of 4.0 ng/mL and lower as normal. Therefore, if a man had a PSA level above 4.0 ng/mL, doctors would often recommend a prostate biopsy to determine whether prostate cancer was present.
However, more recent studies have shown that some men with PSA levels below 4.0 ng/mL have prostate cancer and that many men with higher levels do not have prostate cancer . In addition, various factors can cause a mans PSA level to fluctuate. For example, a mans PSA level often rises if he has prostatitis or a urinary tract infection. Prostate biopsies and prostate surgery also increase PSA level. Conversely, some drugsincluding finasteride and dutasteride , which are used to treat BPHlower a mans PSA level. PSA level may also vary somewhat across testing laboratories.
Another complicating factor is that studies to establish the normal range of PSA levels have been conducted primarily in populations of White men. Although expert opinions vary, there is no clear consensus regarding the optimal PSA threshold for recommending a prostate biopsy for men of any racial or ethnic group.
In general, however, the higher a mans PSA level, the more likely it is that he has prostate cancer. Moreover, a continuous rise in a mans PSA level over time may also be a sign of prostate cancer.
Read Also: What Supplement Is Good For Prostate
Do Some Groups Experience Higher Rates Than Others
Cancer death rates differed by cancer type, sex, racial and ethnic group, and residence in an urban or rural county. Healthy People 2030 objectives include reducing death rates for lung cancerexternal icon to 25.1 deaths per 100,000 population, colorectal cancerexternal icon to 8.9 deaths per 100,000 population, female breast cancerexternal icon to 15.3 deaths per 100,000 female population, and prostate cancerexternal icon to 16.9 deaths per 100,000 male population.
| Characteristic | |
|---|---|
| 19.3 | 18.2 |
NOTES: Deaths were classified using the International Classification of Diseases, 10th Revision. Cancer deaths were identified using underlying cause-of-death codes C00-C97 . Rates were age-adjusted to the 2000 US standard population. Urban/rural status was based on county of residence, classified using the 2013 NCHS Urban-Rural Classification Scheme for Counties.
National Center for Health Statistics, National Vital Statistics System, Mortality Data.
In 2019
- 1,115 children younger than 15 years old died of cancer.
- 9,084 adolescents and young adults between 15 to 39 years old died of cancer.
- 153,928 adults between 40 to 64 years old died of cancer
- 435,462 adults who were 65 years old or older died of cancer.
Note: Age was not recorded for 12 deaths.
National Center for Health Statistics, National Vital Statistics System, Mortality Data.
Reduce The Prostate Cancer Death Rate C08
Objective added to your list.
Objective removed from your list.
Objective added to your list.
Objective removed from your list.
18.3 prostate cancer deaths per 100,000 males
Target:
Baseline:18.8 prostate cancer deaths per 100,000 males occurred in 2018
Reduce the prostate cancer death rate
Also Check: How To Fix A Swollen Prostate
Better Understanding Of Prostate Cancer
Were using the power of big data, working with partners to analyse and combine data from tens of thousands of men whove been diagnosed and treated for different types and stages of prostate cancer. The aim is to find patterns in when the cancers started, how they developed and how aggressive they are. In the future this could help doctors predict how particular prostate cancers are likely to develop so we can choose the most appropriate treatment for each man.
You May Like: Perineural Tumor
What Is The Outlook For Prostate Cancer
The good news is, rates of prostate cancer have dropped considerably in the United States. The National Cancer Institute reports that in 1992 there were 234 new cases for every 100,000 Americans now that figure is under 100 per 100,000. Overall, the American Cancer Society projects 164,690 new cases of prostate cancer in 2018 and 29,430 deaths. From a male US population of 161 million, thats a tiny .02 percent chance of dying from prostate cancer in a given year. Of course, the figures change as you narrow the population based on factors like age, and risk factors like smoking, being overweight and not getting proper exercise. The ACS estimates that 1 in 9 American males will be diagnosed in their lifetime with prostate cancer, and 1 in 41 will die of the disease.
Recommended Reading: What Happens To The Prostate Later In Life
Also Check: Growth On Prostate Is It Cancer
What Are The Risk Factors For Prostate Cancer
The most important factors that increase the risk of prostate cancer are African American race, a family history of prostate cancer, and increasing age. Black men have a 60% higher risk of prostate cancer than white men and are approximately twice as likely to die of prostate cancer. People with a family history of prostate cancer are at increased risk, and having more than one family member with prostate cancer increases the risk further. Older men have a higher risk of prostate cancer than younger men, with more than 50% of all diagnoses occurring after the age of 65 and 97% occurring after the age of 50. There are also certain genetic syndromes that increase the risk of prostate cancer such as BRCA1 and BRCA2 mutations and, as new evidence is suggesting, Lynch Syndrome .
Stage Iv Prostate Cancer Prognosis
Prostate cancers detected at the distant stage have an average five-year survival rate of 28 percent, which is much lower than local and regional cancers of the prostate. This average survival rate represents stage IV prostate cancers that have metastasized beyond nearby areas to lymph nodes, organs or bones in other parts of the body.
How We Treat Prostate Cancer
The prognosis for metastatic prostate cancer can be discouraging, but some treatment centerslike the Johns Hopkins Precision Medicine Center of Excellence for Prostate Cancerspecialize in innovative, individualized therapy with the potential to improve outcomes.
Don’t Miss: Doctors Best Comprehensive Prostate Formula
Racial Disparities In Breast Cancer
There is a persistent mortality gap between Black women and white women when it comes to breast cancer. While the incidence of the disease is similar in both groups, Black women have a 40% higher death rate from breast cancer. The disparity is even greater in the younger demographic: The mortality rate among young Black women is double that of young white women.
The decrease in annual deaths can be attributed to enhanced screening measures and improved treatment options. Prostate cancer is now associated with the best overall outcomes, and the five-year relative survival rate of the disease is 97.8%.
For More Information See Prostate Cancer On The Ncci Website
The National Cancer Control Indicators are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes. The NCCI website allows users to see visual representations of data on each indicator through interactive charts.
Read Also: How Do I Know If I Have A Prostate Infection
Risk Factors And Early Detection
The causes of prostate cancer and the factors influencing its course remain largely unknown. Age is an important risk factor. Men of black African origin develop prostate cancer more frequently than Europeans and white North Americans, while Asians are less often affected. Incidence of the disease among close relatives is a well-established risk factor. In addition, chronic inflammation of the prostate and sexually transmitted diseases appear to increase the risk of prostate cancer.
There is little evidence of lifestyle- or environment-related risk factors. However, maintaining a normal weight and getting sufficient exercise may reduce the risk of prostate cancer.
For men from the age of 45 years, the statutory early detection programme in Germany currently provides an annual check-up, the examination of the external genital organs and the palpation of the prostate and lymph nodes. PSA testing is not part of the statutory early detection program, as the net benefit of population-wide PSA screening has not yet been demonstrated beyond doubt.
It Was Estimated That In :
- 118,200 Canadian men would be diagnosed with cancer and 44,600 men would die from cancer.
- 110,900 Canadian women would be diagnosed with cancer and 40,000 women would die from cancer.
- On average, 628 Canadians would be diagnosed with cancer every day.
- On average, 232 Canadians would die from cancer every day.
- Lung, breast, colorectal and prostate cancer are the most commonly diagnosed types of cancer in Canada .
- These 4 cancers account for 46% of all new cancer cases.
- Prostate cancer accounts for one-fifth of all new cancer cases in men.
- Lung cancer accounts for 13% of all new cases of cancer.
- Breast cancer accounts for one-quarter of all new cancer cases in women
- Colorectal cancer accounts for 11% of all new cancer cases
You May Like: Will Prostate Cancer Show Up On A Pet Scan
Risk Factors For Cancers
Tobacco use, alcohol use, unhealthy diet, physical inactivity and air pollution are risk factors for cancer .
Some chronic infections are risk factors for cancer this is a particular issue in low- and middle-income countries. Approximately 13% of cancers diagnosed in 2018 globally were attributed to carcinogenic infections, including Helicobacter pylori, human papillomavirus , hepatitis B virus, hepatitis C virus, and Epstein-Barr virus .
Hepatitis B and C viruses and some types of HPV increase the risk for liver and cervical cancer, respectively. Infection with HIV substantially increases the risk of cancers such as cervical cancer.
Are Cancer Deaths Rising
The short answer is yes and no. Experts expect the number of cancer deaths in the world to keep going up. Estimates suggest that more than 16 million people will die of cancer by the year 2040. The reason is that there will be more people, and more of them will be older people. In some parts of the world, these things that play a role in certain cancers also are on the rise:
Read Also: How Is Prostate Removal Performed
Deaths From Prostate Cancer
Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. About 1 man in 41 will die of prostate cancer.
Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.1 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
American Cancer Society. Facts & Figures 2021. American Cancer Society. Atlanta, Ga. 2021.
National Cancer Institute. SEER Cancer Stat Facts: Prostate Cancer. Accessed at https://seer.cancer.gov/statfacts/html/prost.html on March 15, 2019.
Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA . SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.
American Cancer Society. Facts & Figures 2021. American Cancer Society. Atlanta, Ga. 2021.
National Cancer Institute. SEER Cancer Stat Facts: Prostate Cancer. Accessed at https://seer.cancer.gov/statfacts/html/prost.html on March 15, 2019.
Last Revised: January 12, 2021
Us Cancer Statistics Data Visualizations Tool
The Data Visualizations tool makes it easy for anyone to explore and use the latest official federal government cancer data from United States Cancer Statistics. It includes the latest cancer data covering the U.S. population.
See how the rates of new prostate cancers or prostate cancer deaths changed over time for the entire United States and individual states.Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website’s privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance on other federal or private website.
Recommended Reading: What Is Localized Prostate Cancer
As Prostate Cancer Deaths Hit All
Today we renew our MANifesto and call for fresh support for our movement in response to new data showing prostate cancer deaths hit a record high of 12,000 in one year.
New nationwide data shows the number of men dying from prostate cancer in the UK has exceeded 12,000 in one year for the first time ever. This is unacceptable. Today we renew our MANifesto to unite the brightest minds in science and healthcare and the most passionate and caring people, to deliver the future men deserve.
Prostate cancer is the most common cancer in men in the UK and is set to be the most commonly diagnosed cancer overall by 2030, as the ageing population grows. Overall a man diagnosed in 2020 has a much-improved chance of survival compared to a man diagnosed 10 years ago, but with the number of affected men increasing, UK-wide data for 2017 showed the highest ever recorded yearly deaths from the disease.
This is despite medical advances in diagnosing and treating prostate cancer and increased national interest in recent years. Now we’re urging action and renewed focus on tackling the problem, with ambitious research plans and a refreshed strategy.
What About Skin Cancer
Melanoma skin cancer is the fifth most common cancer type. Experts expect 6,850 people to die from it in 2020. Thatâs about 1% of all cancer deaths in the U.S.
In recent years, the number of melanoma cases has risen. But the death rate for melanoma has dropped by almost 3% per year from 2008 to 2017.
Don’t Miss: What Helps With Enlarged Prostate
Trend Patterns From 2000 To 2019
Table 2. Patterns of trends in incidence and mortality for prostate cancer from 2000 to 2019 among 89 countries.
In the past two decades, an increasing trend of ASIR for prostate cancer was observed in 65 countries, nearly all countries had high or very high HDI except Tajikistan, and the AAPCs ranged from 0.23% to 4.54% . Meanwhile, significantly increasing mortality trends were also observed in 19 of the 65 countries, with the AAPCs ranging from 0.36% to 3.63% while significantly decreasing mortality trends were also observed in 25 of the 65 countries, with AAPCs ranging from â1.85% to â0.32% . In addition, ASIR and ASMR have been significantly decreasing from 2000 to 2019 in nine countries with a very high HDI, including the Austria, Canada, France, Iceland, Luxembourg, New Zealand, Sweden, Switzerland, and United States of America .
Table 3. Trend analysis of age-standardized incidence for prostate cancer from 2000 to 2019.
Table 4. Trend analysis of age-standardized mortality for prostate cancer from 2000 to 2019.
Figure 3. The AAPC of the ASIR and ASMR of prostate cancer. *P< 0.05. AAPC, Average annual percent change ASIR, age-standardized incidence rate ASMR, age-standardized mortality rate.
Prostate Cancer Incidence And Mortality In 2020
The incidence and mortality of prostate cancer in 2020 of the major countries are shown in Table 1. Globally, more than 1.4 million new prostate cancer cases were diagnosed in 2020. The crude incidence rate was 36.0 per 100,000 males and the ASIR was 30.7 per 100,000 males. Data by continents in Figure 1 showed that, ASIRs in Europe, Latin America and the Caribbean, Northern America and Oceania exceeded 59 per 100,000 males, while ASIRs in Africa and Asia were lower than 30 per 100,000 males. However, the regional distribution of ASMR was quite different, with the highest rate in Africa, followed by Latin America and the Caribbean, Europe, Oceania, Northern America and Asia.
Figure 1. Incidence and mortality of prostate cancer in 2020 by continent. Incidence rate Mortality rate ASIR, age-standardized incidence rate ASMR, age-standardized mortality rate.
ASIRs substantially vary more than 123-fold among 174 countries, wherein the highest ASIR was 110.7 per 100,000 males in Ireland from Northern Europe while the lowest ASIR was 0.9 per 100,000 males in Bhutan from South-Central Asia. Similarly, ASMRs varied by more than 77-fold among 174 countries, from the lowest ASMR of 0.54 per 100,000 males in Bhutan from South-Central Asia to the highest ASMR of 41.7 per 100,000 males in Zimbabwe from Eastern Africa, in which the crude mortality rate was only 12.2 per 100,000 .
Don’t Miss: What Is Malignant Neoplasm Of The Prostate